Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #61,151 to #61,200.
- Euthyroid sick syndrome X-ray (4 revisions)
- Euthyroid sick syndrome screening (4 revisions)
- Evans-Jensen classification (4 revisions)
- Ewing's sarcoma cost-effectiveness of therapy (4 revisions)
- Ewing's sarcoma future or investigational therapies (4 revisions)
- Ewing sarcoma breakpoint region 1 (4 revisions)
- Excretory duct of seminal gland (4 revisions)
- Exercise capacity (4 revisions)
- Exercise intolerance (4 revisions)
- Exophoria (4 revisions)
- Exosome component 2 (4 revisions)
- External cause (4 revisions)
- Extramammary Paget's disease cost-effectiveness of therapy (4 revisions)
- Extramammary Paget's disease future or investigational therapies (4 revisions)
- Extramammary Paget's disease natural history (4 revisions)
- Extranodal NK-T-cell lymphoma future or investigational therapies (4 revisions)
- Exudate (4 revisions)
- Eye drop (4 revisions)
- Eye pain history to be obtained (4 revisions)
- Eye pain pathophysiology (4 revisions)
- Eye pain symptoms (4 revisions)
- Eyelash (4 revisions)
- FABP5 (4 revisions)
- FAM46A (4 revisions)
- FAM83A (4 revisions)
- FANCG (4 revisions)
- FBLN5 (4 revisions)
- FBXL3 (4 revisions)
- FBXW7 (4 revisions)
- FCN2 (4 revisions)
- FDA panel review of ticagrelor on July 28th, 2010 (4 revisions)
- FGF14 (4 revisions)
- FGF21 (4 revisions)
- FGF9 (4 revisions)
- FHOD1 (4 revisions)
- FIP1L1 (4 revisions)
- FITkit (4 revisions)
- FLAMSA regimen (4 revisions)
- FMR1 (4 revisions)
- FNTA (4 revisions)
- FOLFIRINOX regimen (4 revisions)
- FOXG1 (4 revisions)
- FOXO4 (4 revisions)
- FOXP3 (4 revisions)
- FRMD7 (4 revisions)
- FUT8 (4 revisions)
- FZD1 (4 revisions)
- FZD10 (4 revisions)
- FZD2 (4 revisions)
- FZD4 (4 revisions)